Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061880
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2003-06-05
Brief Title:
BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
Sponsor:
BioCryst Pharmaceuticals
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| stage I cutaneous T-cell non-Hodgkin lymphoma | View |
| stage II cutaneous T-cell non-Hodgkin lymphoma | View |
| stage III cutaneous T-cell non-Hodgkin lymphoma | View |
| stage IV cutaneous T-cell non-Hodgkin lymphoma | View |
| recurrent mycosis fungoidesSezary syndrome | View |
| stage I mycosis fungoidesSezary syndrome | View |
| stage II mycosis fungoidesSezary syndrome | View |
| stage III mycosis fungoidesSezary syndrome | View |
| stage IV mycosis fungoidesSezary syndrome | View |